Abstract:In industrialized countries cardiovascular diseases are the major cause of death. The last clinical therapy option for some patients, suffering from terminal heart diseases, is donor heart transplantation. As the available number of donor organs is decreasing, many patients die while waiting for a transplant. For this reason Ventricular Assist Devices (VADs), which can mechanically support the human heart to achieve a sufficient perfusion of the body, are under development. For an implantable VAD, design constraints have to be deduced from the physiological conditions in the human body. In case of a VAD drive, these constraints are for example dimensions, electric losses, which might result in an overheating of blood, and a long durability. Therefore a hybrid permanent magnet hydrodynamic bearing is designed in this paper, which works passively and contactless. Based on Finite Element simulations of magnetic fields, various permanent magnet topologies are studied in terms of axial forces and stiffness.
Drive optimisation of a pulsatile Total Artificial HeartTotal Artificial Hearts (TAHs) are required for the therapy of terminal heart diseases as heart transplants are only a limited option due to the available number of donor hearts. For implantation TAHs have to meet constraints regarding its dimensions, weight, perfusions and electrical losses. An innovative linear driven TAH is presented, which meets all constraints except weight. Therefore the geometry of the linear drive is optimised to reduce its weights while simultaneously limiting the electrical losses as much as possible. In order to calculate the losses, this paper introduced a combined calculation chain consisting of FEM simulations and analytical equations. Based on this chain the linear drive is optmised by the method of parameter variations. The results yield a hierachic order of parameters which are most suitable for the weight reduction of the drive for low losses. By this the weight of the linear drive is reduced by 25%. As the allowable loss limit is not exceeded yet, room for further weight reduction achieved by an optimisation of the axial geomtry parameters is given.
-Worldwide cardiovascular diseases are the major cause of death. Aside from heart transplants, which are limited due to the availability of human donor hearts, artificial hearts are the only therapy available for terminal heart diseases. For various reasons, a total implantable artificial heart is desirable. But the limited space in the human thorax sets rigorous restrictions on the weight and dimensions of the device. Nevertheless, the appropriate functionality of the artificial heart must be ensured and blood damage must be prevented. These requirements set further restrictions to the drive of this device. In the this paper, two optimization methods, namely, the manual parameter variation and Differential Evolution algorithm, are presented and applied to match the specifications of an artificial heart.
Ventricular Assist Devices (VADs) are mechanical blood pumps that support the human heart in order to maintain a sufficient perfusion of the human body and its organs. During VAD operation blood damage caused by hemolysis, thrombogenecity and denaturation has to be avoided. One key parameter causing the blood's denaturation is its temperature which must not exceed 42 °C. As a temperature rise can be directly linked to the losses occuring in the drive system, this paper introduces an efficiency prediction chain for Brushless DC (BLDC) drives which are applied in various VAD systems. The presented chain is applied to various core materials and operation ranges, providing a general overview on the loss dependencies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.